| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4145002
[patent_doc_number] => 06063627
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-16
[patent_title] => 'Methods and vectors for site-specific recombination'
[patent_app_type] => 1
[patent_app_number] => 9/030563
[patent_app_country] => US
[patent_app_date] => 1998-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 50
[patent_no_of_words] => 23319
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/063/06063627.pdf
[firstpage_image] =>[orig_patent_app_number] => 030563
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/030563 | Methods and vectors for site-specific recombination | Feb 24, 1998 | Issued |
Array
(
[id] => 4151796
[patent_doc_number] => 06107057
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-22
[patent_title] => 'Pichia secretory leader for protein expression'
[patent_app_type] => 1
[patent_app_number] => 9/029267
[patent_app_country] => US
[patent_app_date] => 1998-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11983
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/107/06107057.pdf
[firstpage_image] =>[orig_patent_app_number] => 029267
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/029267 | Pichia secretory leader for protein expression | Feb 23, 1998 | Issued |
Array
(
[id] => 4137585
[patent_doc_number] => 06060248
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-09
[patent_title] => 'Process for selecting anti-sense oligonucleotides'
[patent_app_type] => 1
[patent_app_number] => 9/028201
[patent_app_country] => US
[patent_app_date] => 1998-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3668
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/060/06060248.pdf
[firstpage_image] =>[orig_patent_app_number] => 028201
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/028201 | Process for selecting anti-sense oligonucleotides | Feb 22, 1998 | Issued |
Array
(
[id] => 4062767
[patent_doc_number] => 06008018
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-28
[patent_title] => 'ELL2, a new member of an ELL family of RNA polymerase II elongation factors'
[patent_app_type] => 1
[patent_app_number] => 9/026343
[patent_app_country] => US
[patent_app_date] => 1998-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19199
[patent_no_of_claims] => 96
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/008/06008018.pdf
[firstpage_image] =>[orig_patent_app_number] => 026343
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/026343 | ELL2, a new member of an ELL family of RNA polymerase II elongation factors | Feb 18, 1998 | Issued |
| 09/024462 | FORMULATIONS FOR VIRUSES | Feb 16, 1998 | Abandoned |
| 09/025131 | METHOD OF AND COMPOSITE FOR IN SITU FLUORESCENT HYBRIDIZATION | Feb 16, 1998 | Issued |
Array
(
[id] => 3942346
[patent_doc_number] => 05998144
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-07
[patent_title] => 'Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same'
[patent_app_type] => 1
[patent_app_number] => 9/023715
[patent_app_country] => US
[patent_app_date] => 1998-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 9
[patent_no_of_words] => 9879
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/998/05998144.pdf
[firstpage_image] =>[orig_patent_app_number] => 023715
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/023715 | Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same | Feb 12, 1998 | Issued |
Array
(
[id] => 4346415
[patent_doc_number] => 06214578
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Method for the expressing foreign genes and vectors therefor'
[patent_app_type] => 1
[patent_app_number] => 9/011526
[patent_app_country] => US
[patent_app_date] => 1998-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3105
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214578.pdf
[firstpage_image] =>[orig_patent_app_number] => 011526
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/011526 | Method for the expressing foreign genes and vectors therefor | Feb 11, 1998 | Issued |
Array
(
[id] => 4366231
[patent_doc_number] => 06287764
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Class I sequence based typing of HLA-A, -B, and -C alleles by direct DNA sequencing'
[patent_app_type] => 1
[patent_app_number] => 9/021892
[patent_app_country] => US
[patent_app_date] => 1998-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8266
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/287/06287764.pdf
[firstpage_image] =>[orig_patent_app_number] => 021892
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/021892 | Class I sequence based typing of HLA-A, -B, and -C alleles by direct DNA sequencing | Feb 10, 1998 | Issued |
| 09/021706 | MEMBER OF THE TNF FAMILY USEFUL FOR TREATMENT AND DIAGNOSIS OF DISEASE | Feb 9, 1998 | Abandoned |
Array
(
[id] => 4402980
[patent_doc_number] => 06270964
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Protein fragment complementation assays for the detection of biological or drug interactions'
[patent_app_type] => 1
[patent_app_number] => 9/017412
[patent_app_country] => US
[patent_app_date] => 1998-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 22305
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/270/06270964.pdf
[firstpage_image] =>[orig_patent_app_number] => 017412
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/017412 | Protein fragment complementation assays for the detection of biological or drug interactions | Feb 1, 1998 | Issued |
Array
(
[id] => 3905998
[patent_doc_number] => 05897988
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-27
[patent_title] => 'Process and system for selection of mature sperm by surface membrane determinants for assisted reproduction'
[patent_app_type] => 1
[patent_app_number] => 9/010247
[patent_app_country] => US
[patent_app_date] => 1998-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 26
[patent_no_of_words] => 6900
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/897/05897988.pdf
[firstpage_image] =>[orig_patent_app_number] => 010247
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/010247 | Process and system for selection of mature sperm by surface membrane determinants for assisted reproduction | Jan 20, 1998 | Issued |
Array
(
[id] => 4101765
[patent_doc_number] => 06051428
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-18
[patent_title] => 'Rapid production of autologous tumor vaccines'
[patent_app_type] => 1
[patent_app_number] => 9/045476
[patent_app_country] => US
[patent_app_date] => 1998-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 28
[patent_no_of_words] => 15927
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/051/06051428.pdf
[firstpage_image] =>[orig_patent_app_number] => 045476
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/045476 | Rapid production of autologous tumor vaccines | Jan 19, 1998 | Issued |
Array
(
[id] => 4234984
[patent_doc_number] => 06090539
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-18
[patent_title] => 'Methods and compositions utilizing Rad51'
[patent_app_type] => 1
[patent_app_number] => 9/007020
[patent_app_country] => US
[patent_app_date] => 1998-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 21
[patent_no_of_words] => 17148
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/090/06090539.pdf
[firstpage_image] =>[orig_patent_app_number] => 007020
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/007020 | Methods and compositions utilizing Rad51 | Jan 13, 1998 | Issued |
Array
(
[id] => 4291089
[patent_doc_number] => 06180399
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-30
[patent_title] => 'RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods'
[patent_app_type] => 1
[patent_app_number] => 9/005325
[patent_app_country] => US
[patent_app_date] => 1998-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 40
[patent_no_of_words] => 18191
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/180/06180399.pdf
[firstpage_image] =>[orig_patent_app_number] => 005325
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/005325 | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods | Jan 8, 1998 | Issued |
Array
(
[id] => 4301795
[patent_doc_number] => 06326140
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Systems for generating and analyzing stimulus-response output signal matrices'
[patent_app_type] => 1
[patent_app_number] => 8/986650
[patent_app_country] => US
[patent_app_date] => 1997-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 8152
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326140.pdf
[firstpage_image] =>[orig_patent_app_number] => 986650
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/986650 | Systems for generating and analyzing stimulus-response output signal matrices | Dec 7, 1997 | Issued |
| 08/986186 | METHODS FOR GENERATING AND SCREENING NOVEL METABOLIC PATHWAYS | Dec 4, 1997 | Abandoned |
Array
(
[id] => 3937299
[patent_doc_number] => 05871984
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'Compounds and methods for site directed mutations in eukaryotic cells'
[patent_app_type] => 1
[patent_app_number] => 8/982866
[patent_app_country] => US
[patent_app_date] => 1997-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 4837
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/871/05871984.pdf
[firstpage_image] =>[orig_patent_app_number] => 982866
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/982866 | Compounds and methods for site directed mutations in eukaryotic cells | Dec 1, 1997 | Issued |
Array
(
[id] => 3982462
[patent_doc_number] => 05861312
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-19
[patent_title] => 'Nucleic acid encoding mammalian UBR1'
[patent_app_type] => 1
[patent_app_number] => 8/982956
[patent_app_country] => US
[patent_app_date] => 1997-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9405
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/861/05861312.pdf
[firstpage_image] =>[orig_patent_app_number] => 982956
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/982956 | Nucleic acid encoding mammalian UBR1 | Dec 1, 1997 | Issued |
Array
(
[id] => 3863260
[patent_doc_number] => 05795972
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-18
[patent_title] => 'Chimeric mutational vectors having non-natural nucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/982867
[patent_app_country] => US
[patent_app_date] => 1997-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12111
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/795/05795972.pdf
[firstpage_image] =>[orig_patent_app_number] => 982867
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/982867 | Chimeric mutational vectors having non-natural nucleotides | Dec 1, 1997 | Issued |